Goodbye drops: Smart contact lenses release drugs directly into your eye

contact lens release drugs eye drops shutterstock photopixel
Remembering to apply your eye drops every day is a pain. Even when they’re being used to treat serious conditions like glaucoma, which can cause blindness, there is still plenty of evidence that people will default on their medication over time.

Now, there’s an effort to create a contact lens capable of delivering doses of medication to the eye over a prolonged period of time.

“There are data to prove that 50 percent of patients given eye drops for glaucoma will stop taking them,” Dr. Joseph Ciolino, an ophthalmologist at Massachusetts Eye and Ear and an assistant professor at Harvard Medical School, told Digital Trends. “We’re trying to unburden them of that obligation. It’s one more thing people don’t have to remember, a hassle they don’t necessarily have to deal with.” Ciolino is involved with the effort to create the new type of contact lens.

The idea of smart contact lenses is something a number of companies and organizations have been working on. Google, for example, has announced a contact lens project aimed at assisting diabetes patients by constantly measuring the glucose levels in their tears. The work carried out by Ciolino and colleague Dr. Daniel Kohane, director of the Laboratory for Biomaterials and Drug Delivery at Boston Children’s Hospital, is different in that it is more concerned with drug delivery than diagnosis.

The contact lens they created contains a thin film of polymer-encapsulated drug; the polymer controls the speed at which the drug is released. Since the drug film is only on the periphery of the lens, it has no negative impact on the wearer’s ability to see, and still allows the eye to breathe or hydrate properly.

Right now, the lenses have been successfully demonstrated in animal trials using a range of drugs. “We have shown that our contact lenses work with a range of drug types, including antibiotics, antifungals, anti-inflammatories, and glaucoma drugs,” Kohane told Digital Trends.

Emerging Tech

Awesome Tech You Can’t Buy Yet: Write music with your voice, make homemade cheese

Check out our roundup of the best new crowdfunding projects and product announcements that hit the web this week. You may not be able to buy this stuff yet, but it sure is fun to gawk!
Product Review

Chris is the virtual co-pilot phone-obsessives need in their car

Driving while using your phone is dangerous, and often illegal. Meet Chris, the digital assistant for your car that wants to help keep your hands off your phone, and your eyes on the road.

Secure your Excel documents with a password by following these quick steps

Excel documents are used by people and businesses all over the world. Given how often they contain sensitive information, it makes sense to keep them from the wrong eyes. Thankfully, it's easy to secure them with a password.

Whether by the pool or the sea, make a splash with the best waterproof phones

Whether you're looking for a phone you can use in the bath, or you just want that extra peace of mind, waterproof phones are here and they're amazing. Check out our selection of the best ones you can buy.

British Airways’ new Club Suite for business class comes with a door

British Airways is going after a bigger slice of the business class market with the imminent launch of the Club Suite. The plush seating option offers a more private space as well as an easier route to the bathroom.
Smart Home

Sony’s Aibo robot dog can now patrol your home for persons of interest

Sony released the all-new Aibo in the U.S. around nine months ago, and since then the robot dog has (hopefully) been melting owners' hearts with its cute looks and clever tricks. Now it has a new one up its sleeve.
Emerging Tech

The U.S. Army is building a giant VR battlefield to train soldiers virtually

Imagine if the U.S. Army was able to rehearse battlezone scenarios dozens, or even hundreds, or times before settling foot on actual terrain. Thanks to virtual reality, that's now a possibility.
Emerging Tech

Inflating smart pills could be a painless alternative to injections

Could an inflating pill containing hidden microneedles replace painful injections? The creators of the RaniPill robotic capsule think so — and they have the human trials to prove it.
Emerging Tech

A silver bullet is being aimed at the drug-resistant superbugs on the ISS

A bacteria which is benign here on Earth can mutate into a drug-resistant superbug once it enters space. Now this problem is being tackled by a team of microbiologists who have found a way to inhibit the spread of bacteria in the ISS.
Emerging Tech

Tombot is the hyper-realistic dog robot that puts Spot to shame

Forget Boston Dynamics’ Spot! When it comes to robot dogs, the folks behind a new Kickstarter campaign have plans to stake their claim as makers of man’s (and woman’s) newest best friend.
Emerging Tech

Researchers gave alligators headphones and ketamine, and all for a good cause

Researchers in Germany and the United States recently gave ketamine and earphones to alligators to monitor how they process sounds. Here's what it reveals about alligator evolution.
Emerging Tech

Cheese tastes different when it listens to Led Zeppelin, Swiss study finds

A funky new study says that exposing cheese to music changes its aroma and flavor. What’s more, the genre of music matters. Researchers from the Bern University of Arts played music to nine, 22-pound wheels of Emmental cheese.
Emerging Tech

Astronomers plan to beam Earth’s greatest hits into deep space, and you can help

A new project from the SETI Institute (search for extraterrestrial intelligence) will give the public the chance to submit compositions to be beamed into space, with the aim of connecting people around the world through music.
Emerging Tech

Twitter is officially a teenager now. Are we raising a monster?

On March 21, 2006, Jack Dorsey sent the first ever tweet. Thirteen years later, Twitter has fundamentally changed the way we communicate. Here are some of the myriad ways it's done that.